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Purpose. To investigate whether cell penetrating peptides (CPP) de-
rived from human calcitonin (hCT) possess, in addition to cellular
uptake, the capacity to deliver their cargo through epithelial barriers.
Methods. Cellular uptake of hCT(9-32) and permeation of six hCT-
derived peptides, namely, hCT(9-32), hCT(12-32), hCT(15-32),
hCT(18-32), hCT(21-32), and a random sequence of hCT(9-32) were
evaluated in fully organized confluent Madin-Darby canine kidney
(MDCK), Calu-3, and TR146 cell culture models. For comparison,
Tat(47-57) and penetratin(43-58) were investigated. The peptides
were N-terminally labeled with carboxyfluorescein (CF). Uptake in
the well-differentiated epithelial models was observed by confocal
laser scanning microscopy (CLSM), whereas permeation through the
models was analyzed by reversed-phase (RP)-HPLC.
Results. In MDCK epithelium hCT(9-32), Tat(47-57) and penetra-
tin(43-58) demonstrated punctuated cytoplasmic distribution. In
Calu-3, Tat(47-57) and penetratin(43-58) were simultaneously local-
ized in a punctuated cytoplasmic and paracellular distribution,
whereas hCT(9-32) showed strict paracellular distribution. By con-
trast, in TR146 cells, Tat(47-57) was located strictly paracellularily,
whereas penetratin(43-58) showed a punctuated cytoplasmic pattern
and hCT(9-32) both. The transepithelial permeability of all tested
peptides and their cargo was lower than that of paracellular markers.
Conclusions. The CPP uptake pattern depends on both the type of
peptide and the cell culture model. In general, the investigated CPP
have no apparent potential for systemic drug delivery across epithe-
lia. Nevertheless, distinct patterns of cellular distribution may offer a
potential for localized epithelial delivery.
KEY WORDS: cell penetrating peptides; cellular translocation; epi-
thelial permeability; epithelial metabolism; human calcitonin.
INTRODUCTION
Because of the restricted cellular access and permeability
of many polypeptide and nucleic acid therapeutics, interest in
cellular drug delivery systems has been intense. A common
difficulty for more widespread use of these biomacromo-
lecules is their low resistance to extracellular cleavage at the
site of administration and their low penetration and perme-
ation rates in epithelial and endothelial barriers. In order to
overcome these limitations, cell penetrating peptides (CPPs)
may offer unprecedented advantages for intracellular deliv-
ery. In vivo studies in mice with Tat(47-57) actually showed
that this polycationic CPP derived from the human immuno-
deficiency virus Tat protein triggered great expectation as it
appeared to help a marker protein pass several biological
barriers, even the blood brain barrier, after i.p. injection, and
distribute into virtually every organ (1). Most CPPs are de-
rived from naturally occurring protein sequences, which pos-
sess the remarkable ability to cross the plasma membrane and
even reach the nuclear regions of cells. CPPs have been de-
scribed in literature as having the ability to enter a large
number of different cell types (2–8) and facilitate the cellular
translocation of various macromolecular cargos such as pro-
teins (9), DNA oligomers (10), and peptide-nucleic acids
(PNA) (11,12), or particulates like liposomes (13) and mag-
netic nanoparticles (14). In a previous study, we demon-
strated that truncated sequences of the human calcitonin
(hCT) such as hCT(9-32), hCT(12-32), hCT(15-32), and
hCT(18-32), as well as Tat(47-57) and penetratin(43-58), were
internalized in Madin-Darby canine kidney (MDCK) cell
monolayers (15). Additionally, hCT(9-32) was shown to
translocate through the plasma membrane of excised bovine
nasal mucosa (16,17) and to act as a transfer vehicle for green
fluorescent protein (GFP) in this tissue model (18). Tat pep-
tides and penetratin were demonstrated to permeate the
plasma membrane of various cell lines (2–5).
Nevertheless, most in vitro studies have been performed
in proliferating cell cultures, only few in fully organized ab-
sorption barrier models, such as the MDCK epithelial cell
culture model (15,19,20) and the Caco-2 epithelial model
(19,21), and none in endothelial models. We believe, how-
ever, that only fully organized confluent cell barriers repre-
sent relevant in vitro models to study the benefits of CPP in
improving the bioavailability of biomacromolecular therapeu-
tics. The cell culture models MDCK, Calu-3, and TR146 rep-
resent three distinct types of epithelia featuring specialized
properties in terms of cell-to-cell junctions, cell morphology
and function as physiologic absorption barrier. MDCK cells
represent a distal renal epithelial cell line forming a continu-
ous sheet of identically oriented asymmetrical cells joined by
tight junctions. This cell line was chosen as a general model
for columnar-type absorptive epithelia with tight junctions.
When subcultured on proper support, reconstructed cell lay-
ers possess transport and permeability qualities similar to that
of absorptive epithelia in vivo (22). Systemic drug delivery
through airway or buccal epithelium is an attractive concept,
which might be improved using CPP. Calu-3 represents a hu-
man bronchial submucosal adenocarcinoma cell line that
forms tight, polarized, and well differentiated monolayers
with apical microvilli and tight-junctional complexes (23). In
contrast to MDCK, Calu-3 generates extracellular mucus.
Calu-3 monolayers have been described as a potentially use-
ful model when assessing drug permeability in airway epithe-
lia (24,25). Finally, the TR146 cell line originates from a neck
node metastasis of a human buccal carcinoma (26). When
subcultured on filters, TR146 cells express ultrastructural
characteristics similar to normal human buccal epithelium (no
tight junctions) and represents an in vitro model of the human
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buccal epithelium (27) or, in more general terms, for other
stratified squamous epithelia, for example, the rectal or the
vaginal mucosa. It has been successfully used for buccal per-
meability studies (27,28).
The purpose of the current study was to initially compare
the cellular uptake of N-terminally carboxyfluorescein (CF)-
labeled hCT(9-32), Tat(47-57), and penetratin(43-58) in the
three epithelial models. In a second step, we evaluated whe-
ther these peptides—once internalized—would be able to
permeate through confluent MDCK, Calu-3, and TR146 epi-
thelial-type cell layers, which are all representing established
in vitro models for systemic drug delivery.
MATERIALS AND METHODS
Materials
MDCK cells (low resistance, type II) were a gift from the
Biopharmacy group of ETH Zurich (Zurich, Switzerland).
Calu-3 cells were purchased from American Type Culture
Collection ATCC (Rockville, MD, USA), and TR146 cells
from Imperial Cancer Research Technology (London, UK).
Cell culture media, L-glutamine, trypsin-EDTA, penicillin,
streptomycin, and Hanks’ Balanced Salt Solution (HBSS)
were from Life Technologies (Basel, Switzerland). Fetal calf
serum (FCS) for the MDCK cells was obtained from Winiger
AG (Wohlen, Switzerland) and for the TR146 cells from
PAA laboratories (Linz, Austria). For the Calu-3 cells, Fetal-
Clone III serum was from HyClone (Logan, UT, USA). Vitro-
gen collagen was from Nutacon (Leimuiden, Belgium). Cell
culture inserts (polyethylene terephthalate, 0.4-m pore size,
1.6 × 106 pores/cm2, 0.9 and 4.2 cm2 growth area) and com-
panion plates were purchased from Falcon (Becton Dickinson
Labware, Franklin Lakes, NJ, USA). Glass chamber slides
were obtained from Nunc (Wiesbaden, Germany), and 96-
well plates from TPP (Trasadingen, Switzerland).
Hoechst 33342 was purchased from Molecular Probes
(Leiden, Netherlands) and the MTS/PMS cytotoxicity assay
from Promega (Madison, WI, USA). 5-carboxyfluorescein
and 5(6)-carboxyfluorescein (CF) was from Fluka (Buchs,
Switzerland), [3H]-mannitol (19.7 Ci/mmol), [3H]-
polyethyleneglycol-900 (PEG900, 2.02 mCi/g), and [3H]-
polyethyleneglycol-4000 (PEG4000, 1.5 mCi/g) from NEN
Life Science Products, Inc. (Boston, MA, USA). All other
chemicals were from Sigma (St. Louis, MO, USA).
Methods
Synthesis of Peptides, CF-Labeling, and Identification
Linear hCT fragments used for the uptake study were
synthesized according to Rist et al. (29) by automated mul-
tiple solid-phase peptide synthesis using a robot system (Syro,
MultiSynTech, Bochum, Germany), CF-labeled and identi-
fied as described previously (15). For the permeability study,
hCT fragments with a purity of >95% were labeled with the
5-carboxyfluorescein isomer; and the peptides were pur-
chased from NMI (Reutlingen, Germany). Synthesis and
identification of CF-labeled Tat(47-57) and penetratin(43-58)
were performed by the group of Professor B. Gutte (Institute
of Biochemistry, University of Zurich), and carried out as
described previously (15). All synthesized peptide sequences
are compiled in Table I.
Cell Culture
Cells were cultured under standard conditions at 37°C in
a 5% CO2 humidified atmosphere. For all three cultures the
medium was supplemented with 10% (v/v) FCS and 1% peni-
cillin/streptomycin. MDCK was cultured in minimum essen-
tial medium with Earl’s salts (MEM) (30) and Calu-3 and
TR146 in DMEM. For permeability studies, cells were cul-
tured on inserts with a constant density of 2 × 104 cells/cm2 for
MDCK (on 4.2-cm2 insert), 105 cells/cm2 for Calu-3 (on 0.9-
cm2 insert) and 24 × 103 cells/cm2 for TR146 (on 0.9-cm2
insert). For Calu-3, the filters were initially coated with col-
lagen (30 g/ml). The MDCK and TR146 cell cultures were
cultured submerged. Post seeding onto the filter, the Calu-3
cells attached to the filter overnight and the medium was then
removed from the apical compartment to allow the cells to
form a monolayer at an air-liquid interface. Apart from the
absence of liquid in the apical chamber, the Calu-3 cells were
cultured as the TR146 cells (27,31). MDCK monolayers (pas-
sage 227-235) were used after 10 days in culture, Calu-3
monolayers (passage 36-41) after 17 to 19 days, and TR146
multilayers (passage 11-15) after 28 to 30 days. Uptake studies
were performed on glass chamber slides and cytotoxicity as-
says (MTS/PMS assay) in 96-well plates. For these studies, the
cell seeding densities as well as the culturing time were iden-
tical to those used in the permeability study.
Uptake Study
Studies in living Calu-3 monolayers and TR146 multilay-
ers were carried out at 37°C with horizontal mechanical shak-
ing (150 rpm). Cells were grown on glass chamber slides and
equilibrated with HBSS for 30 min prior to the uptake studies.
The buffer was then discarded and the cells further incubated
in HBSS containing the appropriate concentration of CF-
labeled peptides or unconjugated CF for 90 min. The concen-
tration of hCT(9-32), Tat(47-57), and penetratin(43-58) was
40 M, 10 M, and 10 M, respectively. Simultaneously, nu-
clei were stained with 1 g/ml Hoechst 33342. Subsequently,
cells were rinsed three times with HBSS and analyzed by
confocal laser scanning microscopy (CLSM; Zeiss 410 in-
verted microscope, Zurich, Switzerland). Two-dimensional
multichannel image processing was performed using the
IMARIS software (Bitplane AG, Switzerland). MDCK cells
were fixed before analysis (15); Calu-3 and TR146 cells were
non-fixed.
Permeability Study
Prior to permeability measurements, following standard
protocols, confluent MDCK cells were equilibrated for 30
min at 37°C, Calu-3 and TR146 cells for 15 min at room
temperature in HBSS (pH 7.4), and the transepithelial elec-
trical resistance (TEER) was measured using a Millicell-ERS
system (Millipore, Bedford, MA, USA). Permeability of the
CF-labeled peptides, their CF-labeled metabolites, or radio-
active labeled markers across epithelia was assessed in three
different passages of cells in HBSS at 37°C using a plate
shaker for agitation (150 rpm) to ensure mixing and in order
to minimize the aqueous boundary layer. Briefly, 0.8 ml
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(MDCK) or 0.5 ml (Calu-3, TR146) of peptide solution was
added to the apical side and 3 ml (MDCK) or 1.8 ml (Calu-3,
TR146) of HBSS to the basal side. At selected time points, for
a period of 6 h, 200 l samples were withdrawn, added to 10
l of 3.7 M acetic acid, and immediately replaced with 200 l
HBSS. The peptide concentrations were 40 M for CF-
labeled hCT(9-32), hCT(12-32), hCT(15-32), hCT(18-32), and
hCT(21-32) and 10 M for Tat(47-57). CF and the CF-labeled
random sequence of hCT(9-32) at a concentration of 40 M
were used as controls. The random sequence corresponds to
a peptide containing the 24 amino acids of hCT(9-32) in a
random position. The permeability of [3H]-mannitol (4 Ci/
ml), [3H]-PEG900 (0.5 Ci/ml) and [3H]-PEG4000 (1 Ci/ml)
was studied under the same experimental conditions. These
markers were used as standards to validate the cellular integ-
rity of the epithelial cell layer(s) and to monitor passive para-
cellular transport. Radiotracer samples were mixed with 2.0
ml scintillation cocktail (Ultima Gold, Perkin Elmer Life Sci-
ences, Beltsville, MD, USA) and measured by liquid scinti-
graphy (Beckman Counter LS6500, Fullerton, CA, USA). In
order to evaluate the free diffusion of the compounds through
the cell culture inserts, control experiments (with [3H]-manni-
tol, [3H]-PEG900, [3H]-PEG4000, hCT(9-32), Tat(47-57) and
penetratin(43-58)) were performed using inserts and colla-
gen-coated inserts without cells.
Preliminary Metabolism Study
MDCK and Calu-3 cells cultured as for the permeability
studies were incubated with 40 M CF-labeled hCT(9-32) at
37°C and shaking (150 rpm) in the reflection kinetics mode
(32). Briefly, the basal side was blocked with a polystyrene
well plate as an impermeable barrier. Under such conditions
no permeation through the epithelial models occurs, and me-
tabolites accumulate in the apical compartment. At times t
0 (MDCK, Calu-3), 60 min (MDCK, Calu-3) and 6 h
(MDCK), 50-l samples were removed, added to 5 l of 3.7
M acetic acid and analyzed by reversed phase (RP)-HPLC.
For improved sensitivity, fluorescence detection was applied,
i.e., only intact peptide and metabolites carrying the N-
terminal fluorophore were detected. In order to check wheth-
er the emitted fluorescence intensity of the CF was dependent
on the length of the peptide residue, that is, the extent of
metabolism, a second study with Calu-3 was carried out in
parallel (n  3). Samples of 150 l were withdrawn at 0, 20,
40, and 60 min, and the intensity of fluorescence was mea-
sured by fluorescence spectrophotometry (ex 492 nm, em
517 nm) (Varian CARY Eclipse, Zug, Switzerland).
Cytotoxicity (MTS/PMS) Study
Cells cultured in 96-well plates were incubated for 1, 2, 4,
and 24 h with various concentrations of CF-labeled peptides
ranging from 40 M to 100 M for hCT-derived peptides and
from 10 M to 1000 M for Tat(47-57) and penetratin(43-58)
(n  4). Concentrations higher than 100 m of the hCT-
derived peptides were not tested as the peptides had the ten-
dency to aggregate at higher concentrations. As a control, CF
(1 mM) was incubated with the cells (1, 2, 4, and 24 h; n 4).
MDCK cell monolayers were incubated with hCT(9-32),
hCT(18-32), Tat(47-57), and penetratin(43-58). Calu-3 and
TR146 cell layers were incubated with hCT(9-32), hCT(12-
32), Tat(47-57), and penetratin(43-58). At the end of the in-
cubation time, the peptide solutions were discarded and re-
placed by the MTS/PMS solution. Briefly, 100 l of PMS (0.92
mg/ml) was added to 2 ml of MTS (2 mg/ml), 20 l of the
MTS/PMS solution were added to 100 l of serum free me-
dium and incubated with cells for 2 h at 37°C with mechanical
shaking (150 rpm). The absorbance was measured at 490 nm
using a microplate reader (Molecular Devices Corporation,
Sunnyvale, CA, USA). The dehydrogenase activity in un-
treated cells (i.e., cells without peptide treatment) was set at
100%, and the toxic effect of CPP peptides measured as the
relative decrease in enzyme activity.
RP-HPLC
Permeability study samples of CF-labeled hCT-derived
peptides, Tat(47-57), and CF were analyzed by RP-HPLC. A
Table I. Amino Acid Sequences of hCT-Derived Peptides, Tat(47-57), and Penetratin (43-58) and Molecular Weight (MW) of All Compounds
Used in the Current Study
Compound Sequence* MW† (Da)
9‡ 12 15 18 21 24 27 31
hCT(9-32) L G T Y T Q D F N K F H T F P Q T A I G V G A P 2968.8
hCT(12-32) Y T Q D F N K f H T F P Q T A I G V G A P 2697.5
hCT(15-32) D F N K F H T F P Q T A I G V G A P 2305.1
hCT(18-32) K F H T F P Q T A I G V G A P 1928.7
hCT(21-32) T F P Q T A I G V G A P 1516.2
hCT(9-32) Derived
random sequence F L T A G Q N T I Q T P V K T G G H F P F A D Y 2968.8
TAT(47-57) G Y G R K K R R Q R R R G 2031.9
Penetratin (43-58) R Q I K I W F Q N R R M K W K K 2604.7
Mannitol 182
PEG900 ∼900
PEG4000 ∼4000
All peptides are N-terminally ligated with 5(6)-carboxyfluorescein.
* hCT-derived peptides and penetratin(43-57) are C-terminally amidated. Tat(47-57) carries a glycine at both terminals.
† The MW of the peptides include the N-terminal 5(6)-carboxyfluorescein.
‡ Numbering of hCT-derived peptides with respect to native human calcitonin.
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system consisting of a L-7100 pump, an L-7200 autosampler
and a L-7485 fluorescence detector (Merck-Hitachi, VWR
International, Dietikon, Switzerland) was used. A flow rate of
1 ml/min and fluorescence emission detected at 517 nm with
excitation at 492 nm was applied. For analysis of the hCT
peptides and CF, the system was equipped with a Microsorb-
MV100 C18 (150 mm × 4.6 mm, 5 m) column (Varian, Zug,
Switzerland). The gradient was linear from 10% solvent A
(AcCN:water:TFA, 80:19.99:0.01)(v/v/v) and 90% solvent B
(AcCN:water:TFA, 10:89.99:0.01)(v/v/v) to 20% solvent B
over 30 min. The approximate retention times of CF-labeled
hCT(9-32), hCT(12-32), hCT(15-32), hCT(18-32), hCT(21-
32), CF and random sequence hCT(9-32) were 22, 19, 21, 18,
14, 13, and 20, respectively. For analysis of Tat(47-57) and
penetratin(43-58), a LiChrospher 100 RP-18 column (250 mm
× 4 mm, 5 m)(Merck KGaA, Darmstadt, Germany) was
used. Again a linear gradient was applied, starting at 90%
solvent A (water:TFA, 99.9:0.1) (v/v) and 10% solvent B
(AcCN:TFA, 99.925:0.075) (v/v) to 100% solvent B over 41
min. To avoid adhesion of Tat(47-57) in the system, a washing
step with acetic acid succeeded each injection. The approxi-
mate retention time was 17 min for Tat(47-57) and 22 min for
penetratin(43-58). For CF as well as the CF-labeled peptides,
the limit of detection was approximately 2.5 × 10−8 M.
Data Analysis
The effective permeability coefficients, P, were deter-
mined at steady state according to Eq. (1):
P = dCdt ss VA  CD (1)
where (dC/dt)ss is the steady-state slope of the concentration
vs. the time profile in the receiver compartment (corrected for
sample removal), A is the cross-sectional area of the filter
membrane, V is the volume in the receiver chamber, and CD
is the initial concentration in the donor compartment.
Effective permeability values were determined as both
Pintact and Pcumul. Pintact is based on the analysis of intact
peptide alone as quantified by RP-HPLC. Pcumul is the cumu-
lative permeability related to the cumulated fluorescence of all
species in the receiver chamber still carrying the CF cargo,
that is, intact peptide plus N-terminal metabolites detectable in
the receiver samples. Hence, Pintact accounts for the perme-
ability of the intact CF-labeled peptide alone, whereas Pcumul
is a measure for the permeability of ligated CF, irrespective of
whatever peptide residues remain conjugated. No permeation
of free CF was observed upon cellular metabolism. Pcumul has
practical relevance for the cellular translocation of the at-
tached cargo.
The intensity of CF-based fluorescence was observed to
decrease with decreasing amounts of AcCN in the mobile
phase. A linear decrease with the percentage of solvent A
(SA) used for RP-HPLC of hCT peptides was found [Eq. (2)].
Fluorescence intensity = −9.1 × percentage of SA + 804.6 (2)
Therefore, the area under curve (AUC) values of all ob-
served RP-HPLC peaks were normalized before calculating
the permeability of the tested CPP. As a standard, peak areas
were normalized relative to a mix of 50% solvent A and 50%
solvent B. Briefly, for intact peptide and each fluorescent
metabolite, the percentages of solvent A at the respective
retention times were calculated. For each of the peaks, a fac-
tor corresponding to the ratio between the fluorescence in-
tensity at the respective percentage of solvent A and a stan-
dard percentage of 50% solvent A was calculated. The peak
areas of the intact peptide and each metabolite were multi-
plied by this factor in order to transform experimental AUC
into normalized AUC at 50% solvent A. Cumulated normal-
ized AUC were calculated for each time point to create the
respective permeation profile which was then used to calcu-
late Pcumul.
The integrity of the cell culture layers monitored before
and after each permeability study by measuring the TEER
was represented as resistance in ·cm2, corrected for the filter
without cells and normalized to surface area.
Statistical data analysis was performed using the Stu-
dent’s t test with p < 0.05 as the lowest level of significance.
RESULTS
Cellular Uptake of CF-Labeled hCT-Derived Peptides,
Tat(47-57), and Penetratin(43-58)
Confocal laser scanning microscopy (CLSM) micro-
graphs of cellular peptide uptake in Calu-3 monolayers and
TR146 multilayers were compared to CLSM images (images
A–D, Fig. 1) from a previous uptake study in MDCK mono-
layers (15). A complete array of micrographs is given in Fig.
1. No intracellular fluorescence was observed when the cells
were incubated with negative controls, that is, no peptide
(Figs. 1A, 1E, 1I). Further, equimolar amounts of unconju-
gated CF did not result in intracellular fluorescence; yet, in
both Calu-3 and TR146 cells extracellular fluorescence was
observed (data not shown). The CPP hCT(9-32) and hCT(12-
32) demonstrated an identical, punctuated cytoplasmic pat-
tern with a sectorial distribution in the MDCK model (15).
For representation, the intracellular distribution pattern of
hCT(12-32) is illustrated in Fig. 1B. Equally, Tat(47-57) de-
picted a cytoplasmic and punctuated pattern, but with a uni-
form distribution across the MDCK monolayers (Fig. 1C).
With penetratin(43-58), a concomitant staining of the surface
of the plasma membrane in addition to intracellular vesicles
was observed (Fig. 1D). In Calu-3 cell monolayers, hCT(9-32)
demonstrated an extracellular distribution, indicating a para-
cellular accumulation of the fluorescence (Fig. 1F). Both
Tat(47-57) and penetratin(43-58) depicted punctuated cyto-
plasmic as well as extracellular staining in Calu-3 cells (Figs.
1G and 1H). By contrast, the hCT(9-32) peptide in TR146
cells showed both punctuated cytoplasmic and extracellular
distribution (Fig. 1J), whereas Tat(47-57) showed mainly ex-
tracellular staining (Fig. 1K) and penetratin(43-58) a punctu-
ated cytoplasmic pattern (Fig. 1L). In neither of the studies,
significant peptide fluorescence was observed inside the nu-
clei. In a previous study, we demonstrated that both fixed and
non-fixed MDCK cells showed a punctuated cytoplasmic dis-
tribution of the peptides (15).
Transepithelial Permeability of CF-Labeled hCT-Derived
Peptides and Tat(47-57)
The permeability coefficients for the paracellular mark-
ers decreased with increasing MW and for the three epithelial
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models, the order MDCK < Calu-3 < TR146 was observed
(Table II). An exception was mannitol, which had a similar
P value in the MDCK and Calu-3 model. In general, however,
the P values for the CF-labeled hCT-derived peptides and
Tat(47-57) were lower than those of PEG4000 (Fig. 2). In
MDCK, the peptides showed P values, both Pintact and Pcumul,
which were significantly lower than that of PEG4000. In
Calu-3, hardly any intact peptides were found in the receiver
compartments except for Tat(47-57). In these cases, estima-
tions of permeability coefficients were exclusively based on
Pcumul. In TR146 cell layers, however, the permeability of
the peptides was similar to PEG4000. A significant excep-
tion from this rule was the peptide hCT(21-32), demon-
strating a Pcumul comparable to PEG4000 in Calu-3 mono-
layers, and to PEG900 in TR146 monolayers, respectively.
Interestingly, Tat(47-57) demonstrated P values similar to
those of hCT-derived peptides in each of the cell line mod-
els.
The P value for CF permeability across the epithelia was
4.5- to 8.5-fold above that of the peptides. The fluorophore
was therefore not a limiting factor for the transfer of the
peptides (data not shown). Further, all the tested compounds,
except penetratin(43-58), showed significantly higher perme-
ability across filters without cells as compared to filters with
cells. With MDCK and Calu-3, the differences were at least in
the range of one order of magnitude (data not shown). For
TR146, the difference was lower, that is, about 4- to 6-fold,
but still significant. The low permeability coefficient of pe-
netratin(43-58) across the filter without cells (1.35 ± 0.62 ×
10−6 cm/s) may be explained by interaction of the peptide
with the filter. Therefore, penetratin(43-58) was not further
considered for interpretation in the permeability study. The
P values were similar in collagen-coated filters as used for the
Calu-3 cell culture (data not presented). The TEER values
were 111 ± 21  · cm2 (n 68), 362 ± 86  · cm2 (n 54) and
164 ± 79   cm2 (n  58) for MDCK, Calu-3, and TR146,
respectively, and consistent with previously reported data (23,
Table II. Permeability of 3[H]-Mannitol, 3[H}-PEG900, and 3[H]-
PEG4000 Across the Cell Culture Models Used*
3[H]-mannitol
(10−7 cm/s)
3[H]-PEG900
(10−7 cm/s)
3[H]-PEG4000
(10−7 cm/s)
MDCK 7.87 ± 2.25 3.54 ± 0.71 1.43 ± 0.54
Calu-3 6.12 ± 1.19 6.32 ± 0.56 3.30 ± 0.26
TR146 53.0 ± 13.9 26.0 ± 6.15 11.9 ± 0.96
* Mean ± SD (n  3).
Fig. 1. Variable CLSM patterns of cellular uptake of hCT-derived peptides, Tat(47-57), and penetratin(43-58) in confluent and fully differ-
entiated MDCK monolayers (images A–D) (15), Calu-3 cell monolayers (images E–H), and TR146 cell multilayers (images I–L). Cell layers
were incubated without peptide (images A, E, I), with 40 M hCT(12-32) (image B), 40 M hCT(9-32) (images F and J), 10 M Tat(47-57)
(images C, G, K), or 10 M penetratin(43-58) (images D, H, L). The cell nuclei are shown in blue and the peptides in green. Processed CLSM
data sets are illustrated as xy-sections. Bars: 10 m.
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30,31). No significant changes in the TEER values were de-
tected during the 6 h of the permeation experiments.
Metabolism of CF-Labeled hCT(9-32) and Tat(47-57)
When incubated in the presence of the three epithelial
models, the peptides were subject to enzymatic degradation
leading to the appearance of various metabolites. It emerges
from Fig. 3 that the metabolism of hCT(9-32) upon adminis-
tration to the Calu-3 model was almost complete within 60
min generating four to five main N-terminal metabolites. For
MDCK, the metabolism of hCT(9-32) seems significantly
slower, which was also observed with TR146. Contrastingly,
Tat(47-57) was metabolically rather stable in all cell lines
(data not shown). In the RP-HPLC chromatograms, no free
CF was detected as a result of metabolic cleavage upon per-
meation of the cell layers. Further, the emitted fluorescence
intensity of CF was not affected by the degree of metabolism
Fig. 2. Effective permeability coefficients of the CF-labeled hCT-derived peptides and Tat(47-57) in three epithelial models: MDCK, Calu-3,
and TR146. Permeability coefficients of intact peptides, Pintact, (open bars), and cumulative permeability coefficients, Pcumul, of intact peptides
and N-terminal metabolites carrying the fluorescent cargo (scattered bars) are presented. Mean ± SD (n 3). The dashed line indicates the
P value for PEG4000 in each of the cell lines.
Fig. 3. RP-HPLC chromatograms illustrating the metabolic degradation of 40 M CF-labeled hCT(9-32) upon apical application to MDCK
or Calu-3 layers.
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(Table III), that is, quantitation by fluorescence detection and
calculation of Pcumul is not compromised by the extent of
metabolism and thus do not require detailed knowledge of
the rate and kinetics of metabolism.
Cytotoxicity of CF-Labeled hCT-Derived Peptides,
Tat(47-57), and Penetratin(43-58)
In Table IV, the percentages of viable cells after 2 h are
given. No significant differences between the 2-h observations
and shorter or longer incubation periods were observed. Even
at concentrations of up to 100 M and after 24 h of incuba-
tion, hCT-derived peptides, Tat(47-57) and penetratin(43-58)
did not show relevant toxicity (i.e., enzyme activity >90%) in
the three cell types. The exception was penetratin(43-58),
which was observed to be slightly toxic in TR146 even upon
application of 10 M. The loss of viability in TR146 was
12–24% when incubated at concentrations of 10 to 100 M, as
early as after 1 h of treatment. Longer incubation times fur-
ther decreased the enzyme activity to about 37%. Both
Tat(47-57) and penetratin(43-58) showed significant toxicity
at the highest concentration (1000 M) in all three epithelial
models, as detected as early as after 1 h of incubation. Incu-
bation with 1 mM CF did not reveal any indication of toxicity
in any of the applied cell models, even after 24 h (data not
shown). The viability of cells incubated with 70% (v/v) etha-
nol as a positive control decreased approximately 85% (v/v)
within 2 h of incubation (data not shown).
DISCUSSION
In the current study, the cellular uptake and the perme-
ability of CF-labeled hCT-derived peptides, Tat(47-57), and
penetratin(43-58) in three established epithelial cell culture
models were assessed. By CLSM, it was demonstrated that
depending on the peptide and the applied epithelial model,
selected peptides were in fact internalized, whereas others
showed extracellular binding only. The metabolic cleavage
might account for the differences in localization patterns, as
the extent of metabolism seemed dependent on the peptide,
the applied epithelial model and the exposure time. At this
point, the nature of these remarkably contrasting patterns of
intracellular vs. paracellular localization is unknown. Never-
theless, the data calls a cell-type independent mechanism of
CPP internalization (4,33) strongly into question. This con-
firms a previous suggestion of Koppelhus et al., who argued
that the uptake might depend on cell-specific membrane com-
ponents or lipid composition (12). However, the internaliza-
tion efficiency and/or internalization rate of Tat(47-57) and
penetratin(47-57) might be different from that of hCT(9-32)
and hCT(12-32) because lower concentrations were sufficient
to obtain CLSM images. Moreover, our data question the
practical relevance of uptake studies with proliferating cells
only. Apparently, fully organized epithelial-type cultures
show much better discrimination of cellular entry.
By CLSM, a purely intracellular uptake of hCT(9-32) in
MDCK was demonstrated, but in Calu-3 and TR146 a
marked paracellular accumulation correlating with a some-
what better permeation of the peptide and its metabolites
across these barriers was observed. In contrast, Tat(47-57),
which accumulated partly or exclusively in the paracellular
space of Calu-3 and TR146, did not show a higher permeabil-
ity in these two barriers as compared to MDCK cells. This is
in correspondence with a recent study describing that in
MDCK and Caco-2 cells, the permeability of Tat(48-57) was
restricted to a level similar to the paracellular marker [14C]-
inulin (19). It may be speculated whether Tat(47-57) has the
tendency to strongly interact with the plasma membrane of
the cells, hindering its paracellular transport. Furthermore,
this might partly explain the recent report that Tat(44-57)
could not penetrate plasma membranes of MDCK monolay-
Table IV. Cytotoxicity of Selected, CF-Labeled hCT-Derived Peptides, Tat(47-57), and Penetratin(43-
58) After 2 h of Incubation with MDCK, Calu-3, and TR146 Layers
Peptide concentration (M) Peptide concentration (M)
40 80 100 10 50 100 1000
hCT(9-32) Tat(47-57)
MDCK 99.6 ± 0.15 102.0 ± 0.16 101.8 ± 0.21 97.7 ± 0.09 98.1 ± 0.13 98.2 ± 0.11 36.0 ± 0.09
Calu-3 97.2 ± 0.14 97.7 ± 0.10 99.3 ± 0.14 96.0 ± 0.11 98.9 ± 0.15 99.3 ± 0.14 65.4 ± 0.18
TR146 99.8 ± 0.08 102.8 ± 0.05 104.2 ± 0.05 94.1 ± 0.20 96.4 ± 0.15 96.0 ± 0.13 48.4 ± 0.16
hCT(18-32)/hCT(12-32)* Penetratin(43-58)
MDCK 98.8 ± 0.23 104.7 ± 0.23 103.1 ± 0.21 93.5 ± 0.19 95.0 ± 0.12 92.2 ± 0.16 40.9 ± 0.31
Calu-3 98.6 ± 0.09 98.8 ± 0.02 98.8 ± 0.08 95.9 ± 0.10 95.0 ± 0.05 90.6 ± 0.96 70.6 ± 0.11
TR146 99.2 ± 0.05 101.2 ± 0.08 100.8 ± 0.05 83.0 ± 0.19 88.0 ± 0.31 76.4 ± 0.58 44.8 ± 0.09
The data represents the percentage of viable cells relative to a negative control (i.e., cells without
peptide treatment). Mean ± SD (n  4). The concentrations used for uptake and permeability studies
are highlighted.
* hCT(18-32) was incubated with MDCK cell layers; hCT(12-32) with Calu-3 and TR146 layers.
Table III. Cumulated Fluorescence Intensity (ex 492 nm, em 517
nm) During Metabolism of 40 M CF-Labeled hCT(9-32) by Calu-3
Epithelium*
Relative fluorescence (AU)
t  0 min t  20 min t  40 min t  60 min
613.7 ± 5.3 611.0 ± 8.3 630.5 ± 51.9 660.1 ± 40.9
The cumulated fluorescence intensities of intact peptide and metabo-
lites remain essentially constant, that is, the slope of the linear fluo-
rescence versus time regression is not statistically different from zero
(p > 0.05).
Mean ± SD (n  3).
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ers (20), contradicting however our results with Tat(47-57).
The present result that the epithelium is the limiting barrier
for permeability of penetratin(43-58) is in contrast to a recent
study (21).
It was demonstrated that the selected hCT-derived pep-
tides and Tat(47-57) as well as their concomitantly formed
N-terminal metabolites revealed only poor permeation
through the three established epithelial cell cultures. Their
permeability values were in the range or even lower than
those of markers of comparable molecular weights commonly
used to demonstrate passive, paracellular transport. By RP-
HPLC, a distinction between intact peptide and N-terminal
metabolites thereof was possible. The cumulative permeabil-
ity coefficients, Pcumul, were generally higher than those of
intact peptide, Pintact. This strongly indicates the effect of
metabolic degradation of the hCT peptides when crossing the
epithelia, and that, though to a rather limited degree, both
intact peptides and N-terminal metabolites cross the barrier.
Though in Calu-3, Tat(47-57) was capable of delivering intact
peptide into the receiver—at low efficiency, however—all of
the other tested CPP were almost entirely metabolized before
reaching the receiver compartment. The metabolic capacity
of the other epithelial models, MDCK and TR146, seemed
markedly lower. However, as even the metabolically more
stable Tat(47-57) did not show appreciable levels of cargo
permeation, the predominant role of metabolism to explain
the poor levels of CPP permeation in this study must be ex-
cluded. Overall, once translocated into cytoplasmic compart-
ments, the presently tested peptides did not efficiently per-
meate the epithelium. The peptide hCT(21-32) was recently
observed not to internalize into MDCK cells (15). The ab-
sence of internalization could account for the somewhat
higher P of this peptide, even though the lower MW and
metabolism would also contribute to easier diffusion across
the epithelial barriers.
The fact that none of the peptides decreased the TEER
of the epithelial barriers probably explains the low perme-
ability as compared to transportan and its analog, trans-
portan10 (21). Regarding CPP cytotoxicity, only limited in-
formation is available on the cellular toxicity of Tat and
penetratin. Jia et al., for example, demonstrated that the cys-
teine-rich and basic domain of Tat peptide induced endothe-
lial cell apoptosis (34), and Vives et al. showed that 100 M of
Tat(37-60) and Tat(37-53) led to a drop in cell viability of
HeLa cells, whereas the peptides Tat(43-60) and Tat(48-60)
did not induce any significant toxicity during a period of 24 h
(6). For penetratin(43-58), it has been shown that intrastriatal
injection of 10 g caused neurotoxic cell death and 50 M
induced a cytotoxic effect on U2OS osteosarcoma cells (7). In
the current study, Tat(47-57) and penetratin(43-58) demon-
strated a toxic effect on MDCK, Calu-3, and TR146 only at
the highest concentration (1000 M). When incubated under
the same experimental conditions as in the uptake and per-
meability experiments, the hCT-derived peptides and Tat(47-
57) turned out to be nontoxic, and only penetratin(43-58)
revealed a slightly toxic effect, but exclusively in TR146 cells.
As revealed by CLSM, its cytoplasmic uptake pattern was
punctuated, suggesting vesicular localization. Koppelhus et al.
argued that in case of a toxic effect, a strong diffuse staining
of both the cytoplasm and the nuclei could be seen, instead of
a vesicular pattern (12). In summary, except for the unrea-
listically high concentration described above, no significant
toxicity of CF-labeled hCT-derived peptides, Tat(47-57), and
penetratin(43-58) could be detected when incubated with the
three epithelial models. These results are consistent with pre-
vious data performed on MDCK cell monolayers using the
LDH release method (15). Cell line dependent differences in
cellular toxicity may depend on cell-specific membrane com-
ponents or lipid compositions. The observed extent of toxicity
owed to the peptides themselves and not to the fluorophore.
In conclusion, the results show that even after cellular
uptake, none of the hCT-derived peptides nor Tat(47-57)
demonstrates therapeutically relevant transepithelial perme-
ability in the investigated epithelial models. Remarkably,
none of the peptides, except penetratin(43-58) on TR146,
showed any cellular toxicity in the three cell lines tested at
concentrations as high as 100 M CPP during 24 h. We sug-
gest that, once internalized, the peptides cannot permeate the
basolateral barrier of the cells in significant numbers, neither
intact nor after cleavage to a N-terminal metabolite carrying
the fluorescent cargo. When accumulated in the paracellular
space, slightly better permeability values resulted. Hence, the
investigated cell penetrating peptide sequences have no rel-
evant potential for systemic drug delivery across epithelia.
Expectations raised upon the study by Schwarze et al. (1) in
mice, which suggested more or less unlimited access to many
organs and tissues, must therefore be reconsidered. In fact,
the use of CPP for systemic drug delivery in vivo seems to be
questionable, leaving the option of localized delivery of car-
gos to epithelial or other tissues.
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